Loading provider…
Loading provider…
Diagnostic Radiology Physician in Duarte, CA
NPI: 1336315316Primary Employer
City of Hope Medical - San Bernardino Radiation Oncology
cityofhope.org
HQ Phone
Get M.D. PH.D. Phillip's Phone Numberphone_androidMobile
Get M.D. PH.D. Phillip's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CT State Medical License
AZ State Medical License
2009 - 2027
CA State Medical License
2024 - 2026
CT State Medical License
2003 - 2010

American Board of Nuclear Medicine
Nuclear Medicine

American Board of Radiology
Diagnostic Radiology

American Board of Radiology
Nuclear Radiology
UVA School of Medicine
med.virginia.edu
Medical School
Until 2000
Yale-New Haven Medical Center
Residency • Radiology-Diagnostic
2005 - 2008
UCLA David Geffen School of Medicine/UCLA Medical Center
Residency • Internal Medicine
2000 - 2003
Mesh modeling of system geometry and anatomy phantoms for realistic GATE simulations
Authors: Auer, Benjamin, Könik, Arda, Fromme, Timothy J, De Beenhouwer, Jan, Kalluri, Kesava S, Lindsay, Clifford, Furenlid, Lars R, Kuo, Philip H, King, Michael A
Journal: Phys Med Biol
Publication Date: 2023-03-29
A patient with fever, haemoptysis, and tenderness of calf muscles.
Authors: Ding, L W, Kuo, P H, Yang, P C
Journal: Eur Respir J
Practical Application of DaTQUANT with Optimal Threshold for Diagnostic Accuracy
Authors: Neill, Matthew, Fisher, Julia M, Brand, Christine, Lei, Hong, Sherman, Scott J, Chou, Ying-Hui, Kuo, Phillip H
Journal: Tomography
Publication Date: 2021-12-18
Lead Sponsor: AstraZeneca
Collaborators: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Lanabecestat
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, BIOLOGICAL: LY3002813
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Solanezumab, DRUG: Placebo IV, DRUG: Placebo SC, DRUG: LY2599666